• Symposium | ECP for chronic GvHD: Patient eligibility, treatment optimization, and follow-up

  • Aug 9 2024
  • Duración: 30 m
  • Podcast

Symposium | ECP for chronic GvHD: Patient eligibility, treatment optimization, and follow-up

  • Resumen

  • On April 14, 2024, the GvHD Hub held a symposium at the 50th European Society for Bone and Marrow Transplantation (EBMT) Annual Meeting on the role of extracorporeal photopheresis (ECP) in the management of chronic graft-versus-host disease (cGvHD).

    Zinaida Perić, University of Rijeka, Rijeka, HR, shared her thoughts on patient eligibility, treatment optimization, and follow-up after treatment with ECP for cGvHD. She also discussed a case report of a patient with steroid-refractory (SR)-cGvHD, plus retrospective and prospective data on the use of ECP in cGvHD. In addition, she shared the Nordic ECP Quality Group treatment guidelines for SR-cGvHD.

    Hosted on Acast. See acast.com/privacy for more information.

    Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Symposium | ECP for chronic GvHD: Patient eligibility, treatment optimization, and follow-up

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.